Trastuzumab-refractory HER2-positive metastatic breast cancer - Use of tanespimycin, a novel Hsp90 inhibitor Journal Article
| Authors: | Morris, P.; Modi, S. |
| Article Title: | Trastuzumab-refractory HER2-positive metastatic breast cancer - Use of tanespimycin, a novel Hsp90 inhibitor |
| Keywords: | immunohistochemistry; adult; case report; diarrhea; drug withdrawal; capecitabine; cancer radiotherapy; lymph node metastasis; lymph node dissection; carboplatin; mastectomy; etoposide; epidermal growth factor receptor 2; antineoplastic activity; cancer resistance; drug hypersensitivity; postoperative complication; lymphedema; axillary lymph node; breast carcinoma; tanespimycin; heat shock protein 90; tamoxifen; trastuzumab; anastrozole; navelbine; drug substitution; cellulitis |
| Journal Title: | American Journal of Hematology/Oncology |
| Volume: | 7 |
| Issue: | 6 |
| ISSN: | 1939-6163 |
| Publisher: | Haymarket Media Inc. |
| Date Published: | 2008-06-01 |
| Start Page: | 236 |
| End Page: | 239 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 17 November 2011" - "Source: Scopus" |
